Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 572 participants.

Also called NCT01638832

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 572 participants (planned count) (from the registry)
Sponsor
Johann Wolfgang Goethe University Hospital (from the registry)
Registry
  • NCT NCT01638832
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01638832. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-06 (registry gives no type); primary completion 2013-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease
Condition
Nonalcoholic Steatohepatitis (NASH)
Intervention (Device)
Transient Elastography (FibroScan), Echosens, Paris, France
Intervention (Device)
Controlled Attenuation Parameter (CAP), Echosens, Paris, France
Lead sponsor
Johann Wolfgang Goethe University Hospital (class: other)

Record details

Record id
cardio:ct-nct01638832
Content hash
3a4f28dd61b8cfb4ea6ba961769623f73306733664676fc607604582b4490188